Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

WIP1 Promotes Homologous Recombination and Modulates Sensitivity to PARP Inhibitors

K. Burdova, R. Storchova, M. Palek, L. Macurek,

. 2019 ; 8 (10) : . [pub] 20191015

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't

Genotoxic stress triggers a combined action of DNA repair and cell cycle checkpoint pathways. Protein phosphatase 2C delta (referred to as WIP1) is involved in timely inactivation of DNA damage response by suppressing function of p53 and other targets at chromatin. Here we show that WIP1 promotes DNA repair through homologous recombination. Loss or inhibition of WIP1 delayed disappearance of the ionizing radiation-induced 53BP1 foci in S/G2 cells and promoted cell death. We identify breast cancer associated protein 1 (BRCA1) as interactor and substrate of WIP1 and demonstrate that WIP1 activity is needed for correct dynamics of BRCA1 recruitment to chromatin flanking the DNA lesion. In addition, WIP1 dephosphorylates 53BP1 at Threonine 543 that was previously implicated in mediating interaction with RIF1. Finally, we report that inhibition of WIP1 allowed accumulation of DNA damage in S/G2 cells and increased sensitivity of cancer cells to a poly-(ADP-ribose) polymerase inhibitor olaparib. We propose that inhibition of WIP1 may increase sensitivity of BRCA1-proficient cancer cells to olaparib.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025579
003      
CZ-PrNML
005      
20201222160301.0
007      
ta
008      
201125s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cells8101258 $2 doi
035    __
$a (PubMed)31619012
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Burdova, Kamila $u Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, CZ14220 Prague, Czech Republic. kamila.burdova@img.cas.cz.
245    10
$a WIP1 Promotes Homologous Recombination and Modulates Sensitivity to PARP Inhibitors / $c K. Burdova, R. Storchova, M. Palek, L. Macurek,
520    9_
$a Genotoxic stress triggers a combined action of DNA repair and cell cycle checkpoint pathways. Protein phosphatase 2C delta (referred to as WIP1) is involved in timely inactivation of DNA damage response by suppressing function of p53 and other targets at chromatin. Here we show that WIP1 promotes DNA repair through homologous recombination. Loss or inhibition of WIP1 delayed disappearance of the ionizing radiation-induced 53BP1 foci in S/G2 cells and promoted cell death. We identify breast cancer associated protein 1 (BRCA1) as interactor and substrate of WIP1 and demonstrate that WIP1 activity is needed for correct dynamics of BRCA1 recruitment to chromatin flanking the DNA lesion. In addition, WIP1 dephosphorylates 53BP1 at Threonine 543 that was previously implicated in mediating interaction with RIF1. Finally, we report that inhibition of WIP1 allowed accumulation of DNA damage in S/G2 cells and increased sensitivity of cancer cells to a poly-(ADP-ribose) polymerase inhibitor olaparib. We propose that inhibition of WIP1 may increase sensitivity of BRCA1-proficient cancer cells to olaparib.
650    _2
$a protinádorové látky $x farmakologie $7 D000970
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a protein BRCA1 $x metabolismus $7 D019313
650    _2
$a nádory prsu $x metabolismus $7 D001943
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a chromatin $x metabolismus $7 D002843
650    _2
$a poškození DNA $x genetika $x fyziologie $7 D004249
650    _2
$a oprava DNA $x genetika $x fyziologie $7 D004260
650    _2
$a chemorezistence $x účinky léků $7 D019008
650    _2
$a kontrolní body fáze G2 buněčného cyklu $7 D059565
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a homologní rekombinace $x genetika $7 D059765
650    _2
$a lidé $7 D006801
650    _2
$a ftalaziny $x farmakologie $7 D010793
650    _2
$a piperaziny $x farmakologie $7 D010879
650    _2
$a PARP inhibitory $x farmakologie $7 D000067856
650    _2
$a proteinfosfatasa 2C $x antagonisté a inhibitory $x genetika $x metabolismus $7 D000071636
650    _2
$a kontrolní body fáze S buněčného cyklu $7 D059807
650    _2
$a 53BP1 $x metabolismus $7 D000071857
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Storchova, Radka $u Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, CZ14220 Prague, Czech Republic. radka.storchova@img.cas.cz.
700    1_
$a Palek, Matous $u Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, CZ14220 Prague, Czech Republic. matous.palek@img.cas.cz.
700    1_
$a Macurek, Libor $u Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, CZ14220 Prague, Czech Republic. libor.macurek@img.cas.cz.
773    0_
$w MED00194911 $t Cells $x 2073-4409 $g Roč. 8, č. 10 (2019)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31619012 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222160257 $b ABA008
999    __
$a ok $b bmc $g 1599724 $s 1116265
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 8 $c 10 $e 20191015 $i 2073-4409 $m Cells $n Cells $x MED00194911
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...